GB1493993A - Dietary supplement and dietary methods employing said supplement for the treatment of obesity - Google Patents

Dietary supplement and dietary methods employing said supplement for the treatment of obesity

Info

Publication number
GB1493993A
GB1493993A GB21029/75A GB2102975A GB1493993A GB 1493993 A GB1493993 A GB 1493993A GB 21029/75 A GB21029/75 A GB 21029/75A GB 2102975 A GB2102975 A GB 2102975A GB 1493993 A GB1493993 A GB 1493993A
Authority
GB
United Kingdom
Prior art keywords
supplement
dietary
obesity
treatment
amount
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB21029/75A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to GB21029/75A priority Critical patent/GB1493993A/en
Priority to CA252,288A priority patent/CA1065672A/en
Priority to DE19762621215 priority patent/DE2621215A1/en
Priority to US05/686,594 priority patent/US4237118A/en
Priority to NL7605169A priority patent/NL7605169A/en
Priority to FR7614619A priority patent/FR2361878A1/en
Publication of GB1493993A publication Critical patent/GB1493993A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; MAKING THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/152Milk preparations; Milk powder or milk powder preparations containing additives
    • A23C9/1526Amino acids; Peptides; Protein hydrolysates; Nucleic acids; Derivatives thereof
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/16Inorganic salts, minerals or trace elements
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Abstract

1493993 Dietary supplements A N HOWARD 28 April 1976 [16 May 1975] 21029/75 Heading A5B [Also in Division A2] A dietary supplement, contains minerals and vitamins, for use in conjunction with skimmed milk to provide a complete lowcalorie diet for the treatment of obesity in man, in which the amount of the supplement which contains a datum level of 18 mg + 9 mg iron also contains at least 182 mg sodium, at least 308 mg potassium and at least 64 mg magnesium, as well as vitamin A in an amount of at least 750 Ág retinol equivalents, at least 100 i.u. Vitamin D, at least 0.76 mg thiamine, at least 14 mg nicotinic acid (or nicotinamide), and at least 18 mg ascorbic acid, and in which the total calorie content (if any) of that amount of supplement is not greater than 200 Kcals. The supplement may also contain other vitamins and conventional additives.
GB21029/75A 1972-03-06 1975-05-16 Dietary supplement and dietary methods employing said supplement for the treatment of obesity Expired GB1493993A (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GB21029/75A GB1493993A (en) 1975-05-16 1975-05-16 Dietary supplement and dietary methods employing said supplement for the treatment of obesity
CA252,288A CA1065672A (en) 1975-05-16 1976-05-11 Dietary supplement, and dietary methods employing said supplement for the treatment of obesity
DE19762621215 DE2621215A1 (en) 1975-05-16 1976-05-13 DIAL COMPOSITION
US05/686,594 US4237118A (en) 1972-03-06 1976-05-14 Dietary supplement and dietary methods employing said supplement for the treatment of obesity
NL7605169A NL7605169A (en) 1975-05-16 1976-05-14 DIET COMPOSITION AND RELATED DIET PRESCRIPTION FOR THE TREATMENT OF OBESITY.
FR7614619A FR2361878A1 (en) 1975-05-16 1976-05-14 DIETARY SUPPLEMENT AND DIETARY METHODS USING THIS SUPPLEMENT FOR THE TREATMENT OF OBESITY

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB21029/75A GB1493993A (en) 1975-05-16 1975-05-16 Dietary supplement and dietary methods employing said supplement for the treatment of obesity

Publications (1)

Publication Number Publication Date
GB1493993A true GB1493993A (en) 1977-12-07

Family

ID=10155986

Family Applications (1)

Application Number Title Priority Date Filing Date
GB21029/75A Expired GB1493993A (en) 1972-03-06 1975-05-16 Dietary supplement and dietary methods employing said supplement for the treatment of obesity

Country Status (5)

Country Link
CA (1) CA1065672A (en)
DE (1) DE2621215A1 (en)
FR (1) FR2361878A1 (en)
GB (1) GB1493993A (en)
NL (1) NL7605169A (en)

Cited By (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450568A1 (en) * 1978-02-24 1980-10-03 Suomen Laeaeketehdas Oy Salco PROCESS FOR THE PREPARATION OF FOOD PRODUCTS OF WHICH THE CATIONIC COMPOSITION IS PHYSIOLOGICALLY OPTIMIZED AND PRODUCTS PREPARED ACCORDING TO THIS PROCESS
EP0040654A2 (en) * 1980-05-20 1981-12-02 Vitapharm Pharmaceutical Pty Ltd. Electrolyte drink concentrate
USRE31836E (en) * 1979-05-18 1985-02-19 Efamol Limited Pharmaceutical and dietary composition
EP0595006A1 (en) 1992-09-14 1994-05-04 Vesta Medicines (Proprietary) Limited Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
GB2353471A (en) * 1999-07-06 2001-02-28 Daniel Vigdorovich Composition for treating obesity
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL8205030A (en) * 1982-12-29 1984-07-16 Johannes Franciscus Laimboeck FOOD AND ANTI-CARIES ACTION AND METHOD FOR THE PREPARATION THEREOF.
FR2552631B1 (en) * 1983-10-03 1990-10-19 Meram Sa Laboratoires MILK AND MILK PRODUCTS DEPLETED OR NOT IN CALCIUM AND ENRICHED IN MAGNESIUM
DE4212122C2 (en) * 1992-04-10 1999-07-29 Hesch Rolf Dieter Prof Dr Med Dietary low-energy food to support medical and non-medical measures against osteoporosis
BE1006217A6 (en) * 1992-09-10 1994-06-14 Steils Anne Epouse Gerome Milky drink enhanced nutrient.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB810813A (en) * 1955-11-11 1959-03-25 Glaxo Lab Ltd Improvements in or relating to human dietary preparations
US3219454A (en) * 1961-06-15 1965-11-23 Borden Co Low calorie diet
IT945910B (en) * 1971-04-08 1973-05-10 Erra C Spa DIET PRODUCT THAT CAN BE USED AS AN INTERGRATOR OF HUMAN FOOD WITH PARTICULAR REFERENCE TO CHILDHOOD, CONVALESCENCE OF PREGNANCY FROM LACTATION AND BREAST AGE AND PROCEDURES FOR ITS MANUFACTURING
GB1356370A (en) * 1972-03-06 1974-06-12 Howard A N Methods and formulations for the treatment of obesity

Cited By (29)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2450568A1 (en) * 1978-02-24 1980-10-03 Suomen Laeaeketehdas Oy Salco PROCESS FOR THE PREPARATION OF FOOD PRODUCTS OF WHICH THE CATIONIC COMPOSITION IS PHYSIOLOGICALLY OPTIMIZED AND PRODUCTS PREPARED ACCORDING TO THIS PROCESS
USRE31836E (en) * 1979-05-18 1985-02-19 Efamol Limited Pharmaceutical and dietary composition
EP0040654A2 (en) * 1980-05-20 1981-12-02 Vitapharm Pharmaceutical Pty Ltd. Electrolyte drink concentrate
EP0040654A3 (en) * 1980-05-20 1981-12-16 Vitapharm Pharmaceutical Pty Ltd. Electrolyte drink concentrate
EP0595006A1 (en) 1992-09-14 1994-05-04 Vesta Medicines (Proprietary) Limited Pharmaceutical and dietary compositions for the treatment and prophylaxis of metabolic disturbances in infants containing vitamin B6, folic acid and vitamin B12
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
GB2353471A (en) * 1999-07-06 2001-02-28 Daniel Vigdorovich Composition for treating obesity
GB2353471B (en) * 1999-07-06 2004-08-18 Daniel I Vigdorovich Composition for treating obesity and related disorders and using therof
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6667315B2 (en) 2000-02-29 2003-12-23 Medicure International Inc. Cardioprotective phosphonates and malonates
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
NL7605169A (en) 1976-11-18
FR2361878A1 (en) 1978-03-17
DE2621215A1 (en) 1976-12-02
FR2361878B1 (en) 1979-03-02
CA1065672A (en) 1979-11-06

Similar Documents

Publication Publication Date Title
GB1493993A (en) Dietary supplement and dietary methods employing said supplement for the treatment of obesity
US4237118A (en) Dietary supplement and dietary methods employing said supplement for the treatment of obesity
ES8702144A1 (en) Enteral nutritional hypoallergenic formula.
ATE73658T1 (en) DIET SUPPLEMENT TO REDUCE THE RISK OF INFECTION.
DK1001685T3 (en) Food composition containing methionine
EP0575846A3 (en) Food and feedstuff containing lipase inhibitors.
WO1996039050A3 (en) Therapeutic system for dietary health management
DE69806820T2 (en) CALORIOUS NUTRITIONAL COMPOSITION
JPS5342283A (en) Polymer for blood serum separation
Satyanarayana et al. Effect of nutritional deprivation in early childhood on later growth—a community study without intervention
EP0130746A3 (en) Pig feedstuff
KR890003392A (en) Nutritional supplements
FR2618305B1 (en) NUTRITIONAL MIXTURE FOR THE ELDERLY
GB1191246A (en) Vitamin-containing Preparations
Fritz et al. Measurement of the bioavailability of iron, using the rat hemoglobin repletion test
JP2970957B2 (en) Refined pollen nutritional preparation
Mraz Influence of dietary potassium and sodium on cesium-134 and potassium-42 excretion in sheep
AU6513386A (en) Composition to improve cellular metabolism
Rader et al. Copper depletion in Long-Evans rats fed inorganic tin.
Carroll The growth-retarding effect of erucic acid and its relation to requirements for fat-soluble vitamins
Willmer et al. ENZYMATIC AND METABOLIC ADAPTATIONS: I. CHANGES IN INTACT RATS SUBJECTED TO DIETARY MODIFICATIONS
TAKEDA et al. Effects of supplemental dietary oxidized oil and nutrient mixture on lipid peroxidation in red sea bream
DE69405742D1 (en) POLYAMINE NUTRITIONAL AND / OR MEDICINE COMPOSITION
Hunt Potential danger in excess supplements
Hashimoto Protein-Bound Iodine Levels in Children with Nutritional Dystrophy Studies on the Nutrition of Children in Hirosaki Area (26th Report)

Legal Events

Date Code Title Description
PS Patent sealed
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
732 Registration of transactions, instruments or events in the register (sect. 32/1977)
PCNP Patent ceased through non-payment of renewal fee

Effective date: 19930428